Bioventus
BVS
84 hedge funds and large institutions have $178M invested in Bioventus in 2024 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 28 increasing their positions, 22 reducing their positions, and 14 closing their positions.
64% more capital inflows, than outflows
Capital inflows: $11M | Capital outflows: $6.68M
29% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 14
27% more repeat investments, than reductions
Existing positions increased: 28 | Existing positions reduced: 22
5% more funds holding
Funds holding: 80 → 84 (+4)
1.13% more ownership
Funds ownership: 52.87% → 54% (+1.1%)
8% more call options, than puts
Call options by funds: $998K | Put options by funds: $925K
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$1.53M |
| 2 |
Morgan Stanley
New York
|
+$1.23M |
| 3 |
Jane Street
New York
|
+$1.12M |
| 4 |
LSV Asset Management
Chicago,
Illinois
|
+$1.1M |
| 5 |
Goldman Sachs
New York
|
+$879K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KLC
Kent Lake Capital
Reno,
Nevada
|
-$2.81M |
| 2 |
Nantahala Capital Management
New Canaan,
Connecticut
|
-$838K |
| 3 |
American Century Companies
Kansas City,
Missouri
|
-$310K |
| 4 |
6CM
683 Capital Management
New York
|
-$297K |
| 5 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$291K |
BVS Hedge Fund Activity: Q1 2024 in Review
84 of the 6,963 institutional investors tracked by Wall St. Rank reported a position in Bioventus (BVS) for Q1 2024, worth a combined $178M — up 1.4% from $175M a quarter earlier.
Buyers outnumbered sellers: 18 funds opened new BVS positions and 14 closed out — a net gain of 4 holders — while 28 added to existing stakes and 22 trimmed.
The largest buyer was Millennium Management, adding an estimated $1.53M. The largest seller was Kent Lake Capital, exiting entirely with an estimated $2.81M sold.
- 84 institutional investors held Bioventus (BVS) as of Q1 2024, up from 80 in Q4 2023.
- Funds reported $178M of Bioventus stock for Q1 2024, up 1.4% quarter-over-quarter.
- 18 funds opened new Bioventus positions in Q1 2024 and 14 closed out, a net change of +4 holders.
- The largest Bioventus buyer in Q1 2024 was Millennium Management, an estimated $1.53M added.
- The largest Bioventus seller in Q1 2024 was Kent Lake Capital, an estimated $2.81M sold.
Based on aggregated 13F filings for Q1 2024.